Document:

Exhibit 4.2

 

THE REGISTERED HOLDER OF THIS PURCHASE
OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE OPTION EXCEPT AS HEREIN PROVIDED
AND THE REGISTERED HOLDER OF THIS PURCHASE OPTION AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE
OPTION FOR A PERIOD OF ONE YEAR FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) EARLYBIRDCAPITAL, INC. (“EBC”)
OR AN UNDERWRITER OR SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF EBC OR OF ANY SUCH
UNDERWRITER OR SELECTED DEALER, EXCEPT IN ACCORDANCE WITH FINRA RULE 5110(G)(2).

 

THIS PURCHASE OPTION IS NOT EXERCISABLE
PRIOR TO THE LATER OF THE CONSUMMATION BY MEDWORTH ACQUISITION CORP. (“COMPANY”)
OF A MERGER, CAPITAL SHARE EXCHANGE, ASSET ACQUISITION, PLAN OF ARRANGEMENT, RECAPITALIZATION, REORGANIZATION OR OTHER SIMILAR
BUSINESS COMBINATION (“BUSINESS COMBINATION”)(AS DESCRIBED MORE FULLY IN THE COMPANY’S REGISTRATION
STATEMENT (DEFINED HEREIN)) AND ______________, 2014. VOID AFTER 5:00 P.M. NEW YORK CITY LOCAL TIME, ON _________________, 2018.

 

PURCHASE OPTION

 

FOR THE PURCHASE OF

 

___________ SHARES OF COMMON STOCK

 

OF

 

MEDWORTH
acquisition corp.

 

		1.	Purchase Option.

 

THIS CERTIFIES THAT,
in consideration of $_____ duly paid by or on behalf of ____________ (“Holder”), as registered owner
of this Purchase Option, to MedWorth Acquisition Corp.
(“Company”), Holder is entitled, at any time or from time to time upon the later of the consummation
of a Business Combination or ____________, 2014 (“Commencement Date”), and at or before 5:00 p.m., New
York City local time, on the five year anniversary of the effective date (“Effective Date”) of the Company’s
registration statement (“Registration Statement”) pursuant to which shares of common stock, par value
$0.0001 per share (“Common Stock”), are offered for sale to the public (“Offering”),
but not thereafter (“Expiration Date”), to subscribe for, purchase and receive, in whole or in part,
up to ______________ (_______) shares of Common Stock of the Company. If the Expiration Date is a day on which banking institutions
are authorized by law to close, then this Purchase Option may be exercised on the next succeeding day which is not such a day in
accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that
would terminate the Purchase Option. This Purchase Option is initially exercisable at $8.00 per share of Common Stock so purchased;
provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase
Option, including the exercise price per share of Common Stock and the number of shares of Common Stock to be received upon such
exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or
the adjusted exercise price, depending on the context.

 

    	 

    	 

    

 

		2.	Exercise.

 

2.1         Exercise
Form. In order to exercise this Purchase Option, the exercise form attached hereto must be duly executed and completed and
delivered to the Company, together with this Purchase Option and payment of the Exercise Price for the shares of Common Stock being
purchased payable in cash or by certified check or official bank check or through cashless exercise as provided for below. If the
subscription rights represented hereby shall not be exercised at or before 5:00 p.m., New York City local time, on the Expiration
Date this Purchase Option shall become and be void without further force or effect, and all rights represented hereby shall cease
and expire.

 

2.2         Legend.
Each certificate for the securities purchased under this Purchase Option shall bear a legend as follows unless such securities
have been registered under the Securities Act of 1933, as amended (“Act”):

 

“The securities represented
by this certificate have not been registered under the Securities Act of 1933, as amended (“Act”) or applicable state
law. The securities may not be offered for sale, sold or otherwise transferred except pursuant to an effective registration statement
under the Act, or pursuant to an exemption from registration under the Act and applicable state law.”

 

		2.3	Cashless Exercise.

 

2.3.1      Determination
of Amount. In lieu of any cash payment of the Exercise Price required hereunder, this Purchase Option
may be exercised (“Cashless Exercise Right”) by surrendering the Purchase Option in the manner required
by Section 2.1, together with irrevocable instructions to the Company to issue in exchange for the Purchase Option the number
of shares of Common Stock equal to the product of (x) the number of shares of Common Stock underlying the Purchase Option being
exercised multiplied by (y) a fraction, the numerator of which is the Market Value (as defined below) of the Common Stock less
the Exercise Price and the denominator of which is such Market Value. As used herein, the phrase “Market Value” at
any date shall be deemed to mean (i) if the shares of Common Stock are listed on a national securities
exchange or quoted on the Nasdaq National Market, Nasdaq Capital Market or OTC Bulletin Board (or successor exchange), the last
sale price of the shares of Common Stock in the principal trading market for the shares of Common Stock as reported by the exchange,
Nasdaq or FINRA, as the case may be, on the last trading day preceding the date in question; (ii) if the shares of Common Stock
are not listed on a national securities exchange or quoted on the Nasdaq National Market, Nasdaq Capital Market or the OTC Bulletin
Board (or successor exchange), but are traded in the residual over-the-counter market, the last sale price for the shares of Common
Stock on the last trading day preceding the date in question for which such quotations are reported by the Pink Sheets, LLC or
similar publisher of such quotations; and (iii) if the fair market value of the shares of Common Stock cannot be determined pursuant
to clause (i) or (ii) above, such price as the Board of Directors of the Company shall determine, in good faith. 

 

    	2

    	 

    

 

2.3.2      Mechanics
of Cashless Exercise. The Cashless Exercise Right may be exercised by the Holder on any business day on or after the Commencement
Date and not later than the Expiration Date by delivering the Purchase Option to the Company with the duly executed exercise form
attached hereto with the cashless exercise section completed, exercising the Cashless Exercise Right and specifying the total number
of shares of Common Stock the Holder will purchase pursuant to such Cashless Exercise Right.

 

2.4         No
Obligation to Net Cash Settle. Notwithstanding anything to the contrary contained in this Purchase Option, in no event will
the Company be required to net cash settle the exercise of the Purchase Option. The Holder will not be entitled to exercise the
Purchase Option unless it exercises such Purchase Option pursuant to the Cashless Exercise Right or a registration statement is
effective, or an exemption from the registration requirements is available at such time and, if the holder is not able to exercise
the Purchase Option, the Purchase Option will expire worthless.

 

		3.	Transfer.

 

3.1         General Restrictions.
The registered Holder of this Purchase Option, by its acceptance hereof, agrees that it will not sell, transfer, assign, pledge
or hypothecate this Purchase Option (or the shares of Common Stock underlying this Purchase Option) for a period of one year (including
a period of 180 days pursuant to Rule 5110(g)(1) of the Conduct Rules of the Financial Industry Regulatory
Authority (“FINRA”)) following the Effective Date to anyone other than (i) EBC or an underwriter
or selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of EBC or of any such underwriter
or selected dealer. On and after the first anniversary of the Effective Date, transfers to others may be made subject to compliance
with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company
the assignment form attached hereto duly executed and completed, together with the Purchase Option and payment of all transfer
taxes, if any, payable in connection therewith. The Company shall within five business days transfer this Purchase Option on the
books of the Company and shall execute and deliver a new Purchase Option or Purchase Options of like tenor to the appropriate assignee(s)
expressly evidencing the right to purchase the aggregate number of shares of Common Stock purchasable hereunder or such portion
of such number as shall be contemplated by any such assignment.

 

3.2         Restrictions
Imposed by the Act. The securities evidenced by this Purchase Option shall not be transferred unless and until (i) the
Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption from
registration under the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction
of the Company (the Company hereby agreeing that the opinion of Graubard Miller shall be deemed satisfactory evidence of the availability
of an exemption), or (ii) a registration statement relating to such securities has been filed by the Company and declared
effective by the Securities and Exchange Commission (the “Commission”) and compliance with applicable
state securities law has been established.

 

    	3

    	 

    

 

		4.	New Purchase Options to be Issued.

 

4.1         Partial Exercise
or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Option may be exercised or assigned in whole or
in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Option for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax,
the Company shall cause to be delivered to the Holder without charge a new Purchase Option of like tenor to this Purchase Option
in the name of the Holder evidencing the right of the Holder to purchase the number of shares of Common Stock purchasable hereunder
as to which this Purchase Option has not been exercised or assigned.

 

4.2         Lost Certificate.
Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Option
and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Option
of like tenor and date. Any such new Purchase Option executed and delivered as a result of such loss, theft, mutilation or destruction
shall constitute a substitute contractual obligation on the part of the Company.

 

		5.	Registration Rights.

 

5.1         Demand Registration.

 

5.1.1      Grant of
Right. The Company, upon written demand (“Initial Demand Notice”) of the Holder(s) of at least 51%
of the Purchase Options and/or the underlying shares of Common Stock (“Majority Holders”), agrees to
use its best efforts to register (the “Demand Registration”) under the Act on one occasion, all or any
portion of the Purchase Options requested by the Majority Holders in the Initial Demand Notice and all of the shares of Common
Stock underlying such Purchase Options (collectively, the “Registrable Securities”). Subject to the terms
of Section 5.1.6, on such occasion, the Company will use its reasonable best efforts to file a registration statement or a post-effective
amendment to the Registration Statement covering the Registrable Securities within sixty (60) days after receipt of the Initial
Demand Notice and use its reasonable best efforts to have such registration statement or post-effective amendment declared effective
as soon as possible thereafter. The demand for registration may be made at any time beginning on the Commencement Date and ending
on the Expiration Date. The Initial Demand Notice shall specify the number of shares of Registrable Securities proposed to be sold
and the intended method(s) of distribution thereof. The Company will notify all holders of the Purchase Options and/or Registrable
Securities of the demand within ten days from the date of the receipt of any such Initial Demand Notice. Each holder of Registrable
Securities who wishes to include all or a portion of such holder’s Registrable Securities in the Demand Registration (each
such holder including shares of Registrable Securities in such registration, a “Demanding Holder”) shall
so notify the Company within fifteen (15) days after the receipt by the holder of the notice from the Company. Upon any such request,
the Demanding Holders shall be entitled to have their Registrable Securities included in the Demand Registration, subject to Section
5.1.4.

 

5.1.2      Effective
Registration. A registration will not count as a Demand Registration until the registration statement filed with the Commission
with respect to such Demand Registration has been declared effective and the Company has complied with all of its obligations under
this Agreement with respect thereto.

 

    	4

    	 

    

 

5.1.3      Underwritten
Offering. If the Majority Holders so elect and such holders so advise the Company as part of the Initial Demand Notice, the
offering of such Registrable Securities pursuant to such Demand Registration shall be in the form of an underwritten offering.
In such event, the right of any holder to include its Registrable Securities in such registration shall be conditioned upon such
holder’s participation in such underwriting and the inclusion of such holder’s Registrable Securities in the underwriting
to the extent provided herein. All Demanding Holders proposing to distribute their securities through such underwriting shall enter
into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Majority
Holders.

 

5.1.4      Reduction
of Offering. If the managing underwriter or underwriters for a Demand Registration that is to be an underwritten offering advises
the Company and the Demanding Holders in writing that the dollar amount or number of shares of Registrable Securities which the
Demanding Holders desire to sell, taken together with all other shares of Common Stock or other securities which the Company desires
to sell and the shares of Common Stock, if any, as to which registration has been requested pursuant to written contractual piggy-back
registration rights held by other stockholders of the Company who desire to sell, exceeds the maximum dollar amount or maximum
number of shares that can be sold in such offering without adversely affecting the proposed offering price, the timing, the distribution
method, or the probability of success of such offering (such maximum dollar amount or maximum number of shares, as applicable,
the “Maximum Number of Shares”), then the Company shall include in such registration: (i) first,
the Registrable Securities as to which Demand Registration has been requested by the Demanding Holders (pro rata in accordance
with the number of shares that each such Person has requested be included in such registration, regardless of the number of shares
held by each such Person (such proportion is referred to herein as “Pro Rata”)) that can be sold without
exceeding the Maximum Number of Shares; (ii) second, to the extent that the Maximum Number of Shares has not been reached
under the foregoing clause (i), the shares of Common Stock or other securities that the Company desires to sell that can be
sold without exceeding the Maximum Number of Shares; (iii) third, to the extent that the Maximum Number of Shares has not been
reached under the foregoing clauses (i) and (ii), the shares of Common Stock or other securities registrable pursuant to the terms
of the Registration Rights Agreement entered into by the Company on __________, 2013 (the “Registration Rights Agreement”
and such registrable securities, the “Investor Securities”) as to which “piggy-back” registration
has been requested by the holders thereof, Pro Rata, that can be sold without exceeding the Maximum Number of Shares; and (iv) fourth,
to the extent that the Maximum Number of Shares have not been reached under the foregoing clauses (i), (ii), and (iii), the
shares of Common Stock or other securities for the account of other persons that the Company is obligated to register pursuant
to written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Shares.

 

    	5

    	 

    

 

5.1.5      Withdrawal.
If a majority-in-interest of the Demanding Holders disapprove of the terms of any underwriting or are not entitled to include all
of their Registrable Securities in any offering, such majority-in-interest of the Demanding Holders may elect to withdraw from
such offering by giving written notice to the Company and the underwriter or underwriters of their request to withdraw prior to
the effectiveness of the registration statement filed with the Commission with respect to such Demand Registration. If the majority-in-interest
of the Demanding Holders withdraws from a proposed offering relating to a Demand Registration, then either the Demanding Holders
shall reimburse the Company for the costs associated with the withdrawn registration (in which case such registration shall not
count as a Demand Registration provided for in Section 5.1) or the withdrawn registration shall count as a Demand Registration
provided for in Section 5.1.

 

5.1.6      Terms.
The Company shall bear all reasonable fees and expenses attendant to registering the Registrable Securities, including the expenses
of one legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities, but the
Holders shall pay any and all underwriting commissions. The Company agrees to use its reasonable best efforts to qualify or register
the Registrable Securities in such states as are reasonably requested by the Majority Holder(s); provided, however, that in no
event shall the Company be required to register the Registrable Securities in a state in which such registration would cause (i)
the Company to be obligated to qualify to do business in such state, or would subject the Company to taxation as a foreign corporation
doing business in such jurisdiction or (ii) the principal stockholders of the Company to be obligated to escrow their shares
of capital stock of the Company. The Company shall use its reasonable best efforts to cause any registration statement filed pursuant
to the demand rights granted under Section 5.1.1 to remain effective for a period of nine consecutive months from the effective
date of such registration statement or post-effective amendment; provided, however, that the Company shall have the right to defer
the filing or defer or suspend the effectiveness of any Demand Registration for up to ninety (90) days, and any Piggy-Back Registration
for such period as may be applicable to deferment of any demand registration to which such Piggy-Back Registration relates, in
each case if the Company shall furnish to the holders a certificate signed by the President or Chairman of the Board of the Company
stating that, in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company
and its shareholders for such Registration Statement to be effected at such time; provided further, however, that the Company shall
not have the right to exercise the right set forth in the immediately preceding proviso for more than a total of ninety (90) days
in any 365-day period in respect of a Demand Registration hereunder.

 

    	6

    	 

    

 

		5.2	Piggy-Back Registration.

 

5.2.1      Piggy-Back
Rights. If at any time during the seven year period commencing on the Effective Date the Company proposes to file a registration
statement under the Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable
for, or convertible into, equity securities, by the Company for its own account or for stockholders of the Company for their account
(or by the Company and by stockholders of the Company including, without limitation, pursuant to Section 5.1), other than a registration
statement (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange offer or
offering of securities solely to the Company’s existing stockholders, (iii) for an offering of debt that is convertible
into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall (x) give written notice
of such proposed filing to the holders of Registrable Securities as soon as practicable but in no event less than ten (10) days
before the anticipated filing date, which notice shall describe the amount and type of securities to be included in such offering,
the intended method(s) of distribution, and the name of the proposed managing underwriter or underwriters, if any, of the offering,
and (y) offer to the holders of Registrable Securities in such notice the opportunity to register the sale of such number of shares
of Registrable Securities as such holders may request in writing within five (5) days following receipt of such notice (a “Piggy-Back
Registration”). The Company shall cause such Registrable Securities to be included in such registration and shall
use its reasonable best efforts to cause the managing underwriter or underwriters of a proposed underwritten offering to permit
the Registrable Securities requested to be included in a Piggy-Back Registration on the same terms and conditions as any similar
securities of the Company and to permit the sale or other disposition of such Registrable Securities in accordance with the intended
method(s) of distribution thereof. All holders of Registrable Securities proposing to distribute their securities through a Piggy-Back
Registration that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the
underwriter or underwriters selected for such Piggy-Back Registration. The Company shall continue to provide the notice referred
to above to the Holders for each applicable registration statement to be filed (during the period in which the Purchase Option
is exercisable) by the Company until such time as all of the Registrable Securities have been registered and sold.

 

5.2.2      Reduction
of Offering. If the managing underwriter or underwriters for a Piggy-Back Registration that is to be an underwritten offering
advises the Company and the holders of Registrable Securities in writing that the dollar amount or number of shares of Common Stock
which the Company desires to sell, taken together with shares of Common Stock, if any, as to which registration has been demanded
pursuant to written contractual arrangements with persons other than the holders of Registrable Securities hereunder and the Registrable
Securities as to which registration has been requested under this Section 5.2, exceeds the Maximum Number of Shares, then the Company
shall include in any such registration:

 

(a)         If the registration
is undertaken for the Company’s account: (A) first, the shares of Common Stock or other securities that the Company
desires to sell that can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum
Number of Shares has not been reached under the foregoing clause (A), the shares of Common Stock or other securities, if any,
comprised of Registrable Securities and Investor Securities, as to which registration has been requested pursuant to the applicable
written contractual piggy-back registration rights of such security holders, Pro Rata, that can be sold without exceeding the Maximum
Number of Shares; and (C) third, to the extent that the Maximum Number of shares has not been reached under the foregoing
clauses (A) and (B), the shares of Common Stock or other securities for the account of other persons that the Company is obligated
to register pursuant to written contractual piggy-back registration rights with such persons and that can be sold without exceeding
the Maximum Number of Shares;

 

    	7

    	 

    

 

(b)         If the registration
is a “demand” registration undertaken at the demand of holders of Investor Securities, (A) first, the shares of
Common Stock or other securities for the account of the demanding persons, Pro Rata, that can be sold without exceeding the Maximum
Number of Shares; (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A),
the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum
Number of Shares; (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A)
and (B), the shares of Registrable Securities, Pro Rata, as to which registration has been requested pursuant to the terms hereof,
that can be sold without exceeding the Maximum Number of Shares; and (D) fourth, to the extent that the Maximum Number of
Shares has not been reached under the foregoing clauses (A), (B) and (C), the shares of Common Stock or other securities for
the account of other persons that the Company is obligated to register pursuant to written contractual arrangements with such persons,
that can be sold without exceeding the Maximum Number of Shares; and

 

(c)         If the registration
is a “demand” registration undertaken at the demand of persons other than either the holders of Registrable Securities
or of Investor Securities, (A) first, the shares of Common Stock or other securities for the account of the demanding persons that
can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum Number of Shares has not
been reached under the foregoing clause (A), the shares of Common Stock or other securities that the Company desires to sell that
can be sold without exceeding the Maximum Number of Shares; (C) third, to the extent that the Maximum Number of Shares has not
been reached under the foregoing clauses (A) and (B), collectively the shares of Common Stock or other securities comprised of
Registrable Securities and Investor Securities, Pro Rata, as to which registration has been requested pursuant to the terms hereof
and of the Registration Rights Agreement, as applicable, that can be sold without exceeding the Maximum Number of Shares; and (D)
fourth, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A), (B) and (C), the
shares of Common Stock or other securities for the account of other persons that the Company is obligated to register pursuant
to written contractual arrangements with such persons, that can be sold without exceeding the Maximum Number of Shares.

 

5.2.3      Withdrawal.
Any holder of Registrable Securities may elect to withdraw such holder’s request for inclusion of Registrable Securities
in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of
the registration statement. The Company (whether on its own determination or as the result of a withdrawal by persons making a
demand pursuant to written contractual obligations) may withdraw a registration statement at any time prior to the effectiveness
of the registration statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the holders
of Registrable Securities in connection with such Piggy-Back Registration as provided in Section 5.2.4.

 

5.2.4      Terms.
The Company shall bear all reasonable fees and expenses attendant to registering the Registrable Securities, including the reasonable
expenses of one legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities
but the Holders shall pay any and all underwriting commissions related to the Registrable Securities.

 

    	8

    	 

    

 

		5.3	Indemnification.

 

5.3.1      Indemnification
by the Company. The Company agrees to indemnify and hold harmless each Holder of Registrable Securities, and each of their
respective officers, employees, affiliates, directors, partners, members, attorneys and agents, and each person, if any, who controls
a Holder of Registrable Securities (within the meaning of Section 15 of the Securities Act or Section 20 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”) (each, a “Holder Indemnified Party”),
from and against any expenses, losses, judgments, claims, damages or liabilities, whether joint or several, arising out of or based
upon any untrue statement (or allegedly untrue statement) of a material fact contained in any registration statement under which
the sale of such Registrable Securities was registered under the Act, any preliminary prospectus, final prospectus or summary prospectus
contained in the registration statement, or any amendment or supplement to such registration statement, or arising out of or based
upon any omission (or alleged omission) to state a material fact required to be stated therein or necessary to make the statements
therein not misleading, or any violation by the Company of the Act or any rule or regulation promulgated thereunder applicable
to the Company and relating to action or inaction required of the Company in connection with any such registration; and the Company
shall promptly reimburse the Holder Indemnified Party for any legal and any other expenses reasonably incurred by such Holder Indemnified
Party in connection with investigating and defending any such expense, loss, judgment, claim, damage, liability or action; provided,
however, that the Company will not be liable in any such case to the extent that any such expense, loss, claim, damage or liability
arises out of or is based upon any untrue statement or allegedly untrue statement or omission or alleged omission made in such
registration statement, preliminary prospectus, final prospectus, or summary prospectus, or any such amendment or supplement, in
reliance upon and in conformity with information furnished to the Company, in writing, by such selling holder expressly for use
therein, or is based on any selling holder’s violation of the federal securities laws (including Regulation M) or failure
to sell the Registrable Securities in accordance with the plan of distribution contained in the prospectus.

 

5.3.2      Indemnification
by Holders of Registrable Securities. Each selling Holder of Registrable Securities will, in the event that any registration
is being effected under the Act pursuant to this Agreement of any Registrable Securities held by such selling Holder, indemnify
and hold harmless the Company, each of its directors and officers, and each other selling Holder and each other person, if any,
who controls another selling holder within the meaning of the Act, against any losses, claims, judgments, damages or liabilities,
whether joint or several, insofar as such losses, claims, judgments, damages or liabilities (or actions in respect thereof) arise
out of or are based upon any untrue statement or allegedly untrue statement of a material fact contained in any registration statement
under which the sale of such Registrable Securities was registered under the Act, any preliminary prospectus, final prospectus
or summary prospectus contained in the registration statement, or any amendment or supplement to the registration statement, or
arise out of or are based upon any omission or the alleged omission to state a material fact required to be stated therein or necessary
to make the statement therein not misleading, if the statement or omission was made in reliance upon and in conformity with information
furnished in writing to the Company by such selling Holder expressly for use therein, or is based on any selling Holder’s
violation of the federal securities laws (including Regulation M) or failure to sell the Registrable Securities in accordance with
the plan of distribution contained in the prospectus, and shall reimburse the Company, its directors and officers, and each other
selling Holder or controlling person for any legal or other expenses reasonably incurred by any of them in connection with investigation
or defending any such loss, claim, damage, liability or action. Each selling Holder’s indemnification obligations hereunder
shall be several and not joint and shall be limited to the amount of any net proceeds actually received by such selling Holder.

 

    	9

    	 

    

 

		5.4	General Terms.

 

5.4.1      Exercise
of Purchase Options. Nothing contained in this Purchase Option shall be construed as requiring the Holder(s) to exercise their
Purchase Options prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

5.4.2      Documents
Delivered to Holders. With respect to any registration effected pursuant to an underwritten public offering, the Company shall
furnish EBC, as representative of the Holders participating in such offering, a signed counterpart, addressed to the participating
Holders, of (i) an opinion of counsel to the Company dated the date of the closing under any underwriting agreement related thereto,
and (ii) a “cold comfort” letter dated the date of the closing under the underwriting agreement signed by the independent
public accountants who have issued a report on the Company’s financial statements included in such registration statement,
in each case covering the matters with respect to such registration statement (and the prospectus included therein) and, in the
case of such accountants’ letter, with respect to events subsequent to the date of such financial statements, as are required
to be covered in the opinion of issuer’s counsel and in accountants’ letters delivered to the underwriters in the underwritten
public offering. Additionally, in all registrations effected hereunder, the Company shall also deliver promptly to EBC, as representative
of the Holders participating in the offering, the correspondence and memoranda described below and copies of all correspondence
between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or
its staff with respect to the registration statement and permit EBC, as representative of the Holders, to do such investigation,
upon reasonable advance notice, with respect to information contained in or omitted from the registration statement as it deems
reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books,
records and properties and opportunities to discuss the business of the Company with its officers and independent auditors, all
to such reasonable extent and at such reasonable times and as often as EBC, as representative of the Holders, shall reasonably
request. The Company shall not be required to disclose any confidential information or other records to EBC, as representative
of the Holders, or to any other person, until and unless such persons shall have entered into reasonable confidentiality agreements
(in form and substance reasonably satisfactory to the Company), with the Company with respect thereto.

 

5.4.3      Underwriting
Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any
Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably
acceptable to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and
such managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms
as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting
agreement relating to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the
representations, warranties and covenants of the Company to or for the benefit of such underwriters shall also be made to and for
the benefit of such Holders. Such Holders shall not be required to make any representations or warranties to or agreements with
the Company or the underwriters except as they may relate to such Holders and their intended methods of distribution. Such Holders,
however, shall agree to such covenants and indemnification and contribution obligations for selling stockholders as are customarily
contained in agreements of that type used by the managing underwriter. Further, such Holders shall execute appropriate custody
agreements and otherwise cooperate fully in the preparation of the registration statement and other documents relating to any offering
in which they include Registrable Securities pursuant to this Section 5. Each Holder shall also promptly upon request furnish to
the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of
such Registrable Securities as shall be reasonably required to effect the registration of the Registrable Securities.

 

    	10

    	 

    

 

5.4.4      Rule 144
Sale. Notwithstanding anything contained in this Section 5 to the contrary, the Company shall have no obligation pursuant to
Sections 5.1 or 5.2 to use its best efforts to obtain the registration of Registrable Securities held by any Holder where such
Holder would then be entitled to sell under Rule 144 within any three-month period (or such other period prescribed under Rule
144 as may be provided by amendment thereof) all of the Registrable Securities then held by such Holder.

 

5.4.5      Supplemental
Prospectus. Each Holder agrees, that upon receipt of any notice from the Company of the happening of any event as a result
of which the prospectus included in the registration statement, as then in effect, includes an untrue statement of a material fact
or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light
of the circumstances then existing, such Holder will immediately discontinue disposition of Registrable Securities pursuant to
the registration statement covering such Registrable Securities until such Holder’s receipt of the copies of a supplemental
or amended prospectus, and, if so desired by the Company, such Holder shall deliver to the Company (at the expense of the Company)
or destroy (and deliver to the Company a certificate of such destruction) all copies, other than permanent file copies then in
such Holder’s possession, of the prospectus covering such Registrable Securities current at the time of receipt of such notice.

 

		6.	Adjustments.

 

6.1          Adjustments
to Exercise Price and Number of Securities. The Exercise Price and the number of shares of Common Stock underlying the Purchase
Option shall be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1      Stock Dividends
- Split-Ups. If after the date hereof, and subject to the provisions of Section 6.4 below, the number of outstanding shares
of Common Stock is increased by a stock dividend payable in shares of Common Stock or by a split-up of shares of Common Stock or
other similar event, then, on the effective date thereof, the number of shares of Common Stock purchasable hereunder shall be increased
in proportion to such increase in outstanding shares. In such case, the exercise price applicable thereto shall be proportionately
decreased. For example, if the Company declares a two-for-one stock dividend and at the time of such dividend this Purchase Option
is exercisable for the purchase of one share of Common Stock at $8.00 per share, upon effectiveness of the dividend, this Purchase
Option will be adjusted to allow for the purchase of two shares of Common Stock at $4.00 per share.

 

    	11

    	 

    

 

6.1.2      Aggregation
of Shares. If after the date hereof, and subject to the provisions of Section 6.4, the number of outstanding shares of Common
Stock is decreased by a reverse stock split, consolidation, combination or reclassification of shares of Common Stock or other
similar event, then, on the effective date thereof, the number of shares of Common Stock purchasable hereunder shall be decreased
in proportion to such decrease in outstanding shares. In such case, the exercise price applicable thereto
shall be proportionately increased. 

 

6.1.3      Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common
Stock other than a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such shares of Common
Stock or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation
or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization
of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the property
of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Holder of
this Purchase Option shall have the right thereafter (until the expiration of the right of exercise of this Purchase Option) to
receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the
kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the number of shares of Common
Stock of the Company obtainable upon exercise of this Purchase Option immediately prior to such event; and if any reclassification
also results in a change in shares of Common Stock covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant
to Sections 6.1.1, 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications,
reorganizations, mergers or consolidations, sales or other transfers.

 

6.1.4      Changes in
Form of Purchase Option. This form of Purchase Option need not be changed because of any change pursuant to this Section, and
Purchase Options issued after such change may state the same Exercise Price and the same number of shares of Common Stock as are
stated in the Purchase Options initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new
Purchase Options reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring
after the Commencement Date or the computation thereof.

 

		6.2	[Intentionally Omitted]

 

6.3          Substitute
Purchase Option. In case of any consolidation of the Company with, or merger of the Company with, or merger of the Company
into, another corporation (other than a consolidation or merger which does not result in any reclassification or change of the
outstanding shares of Common Stock), the corporation formed by such consolidation or merger shall execute and deliver to the Holder
a supplemental Purchase Option providing that the holder of each Purchase Option then outstanding or to be outstanding shall have
the right thereafter (until the stated expiration of such Purchase Option) to receive, upon exercise of such Purchase Option, the
kind and amount of shares of stock and other securities and property receivable upon such consolidation or merger, by a holder
of the number of shares of Common Stock of the Company for which such Purchase Option might have been exercised immediately prior
to such consolidation, merger, sale or transfer. Such supplemental Purchase Option shall provide for adjustments which shall be
identical to the adjustments provided in Section 6. The above provision of this Section shall similarly apply to successive consolidations
or mergers.

 

    	12

    	 

    

 

6.4          Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of shares of Common
Stock upon the exercise of the Purchase Option, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests,
it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction to the nearest whole
number of shares of Common Stock or other securities, properties or rights.

 

7.           Reservation
and Listing. The Company shall at all times reserve and keep available out of its authorized shares of Common Stock, solely
for the purpose of issuance upon exercise of the Purchase Options, such number of shares of Common Stock or other securities, properties
or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase
Options and payment of the Exercise Price therefor, all shares of Common Stock and other securities issuable upon such exercise
shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any stockholder. As long
as the Purchase Options shall be outstanding, the Company shall use its best efforts to cause all shares of Common Stock issuable
upon exercise of the Purchase Options to be listed (subject to official notice of issuance) on all securities exchanges (or, if
applicable on the Nasdaq National Market, Capital Market, OTC Bulletin Board or any successor trading market) on which the shares
of Common Stock issued to the public in connection herewith may then be listed and/or quoted.

 

		8.	Certain Notice Requirements.

 

8.1         Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent as a
stockholder for the election of directors or any other matter, or as having any rights whatsoever as a stockholder of the Company.
If, however, at any time prior to the expiration of the Purchase Options and their exercise, any of the events described in Section
8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen days
prior to the date fixed as a record date or the date of closing the transfer books for the determination of the stockholders entitled
to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed
dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer
books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given
to the other stockholders of the Company at the same time and in the same manner that such notice is given to the stockholders.

 

    	13

    	 

    

 

8.2         Events
Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the following
events: (i) if the Company shall take a record of the holders of its shares of Common Stock for the purpose of entitling them
to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than
out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
or (ii) the Company shall offer to all the holders of its shares of Common Stock any additional shares of capital stock of the
Company or securities convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant
to subscribe therefor, or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation
or merger) or a sale of all or substantially all of its property, assets and business shall be proposed.

 

8.3         Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant
to Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price
Notice shall describe the event causing the change and the method of calculating same and shall be certified as being true and
accurate by the Company’s Chief Executive Officer and Chief Financial Officer.

 

8.4         Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Option shall be in writing and shall
be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
Holder of the Purchase Option, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company,
to the following address or to such other address as the Company may designate by notice to the Holders:

 

MedWorth Acquisition
Corp.

999 Brickell Avenue

Suite 800

Miami, Florida
33131

Fax No.: (305)
395-5219

Attn: Chief Executive
Officer

 

		9.	Miscellaneous.

 

9.1         Amendments.
The Company and EBC may from time to time supplement or amend this Purchase Option without the approval of any of the Holders in
order to cure any ambiguity or resolve any question arising hereunder, to correct or supplement any provision contained herein
that may be defective or inconsistent with any other provisions herein, or to make any other changes in regard to terms of this
Purchase Option that the Company and EBC may deem necessary and/or desirable.

 

9.2         Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
meaning or interpretation of any of the terms or provisions of this Purchase Option.

 

9.3         Entire Agreement.
This Purchase Option (together with the other agreements and documents being delivered pursuant to or in connection with this Purchase
Option) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes all prior
agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

    	14

    	 

    

 

9.4         Binding Effect.
This Purchase Option shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted
assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have any
legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Option or any provisions herein
contained.

 

9.5         Governing
Law; Submission to Jurisdiction. This Purchase Option shall be governed by and construed and enforced in accordance with the
laws of the State of New York, without giving effect to conflict of laws. In the event of any dispute under this Purchase Option,
then and in such event, each party hereto agrees that the dispute shall either be (i) submitted to the American Arbitration Association
(“Association”) in New York County, New York, for its decision and determination in accordance with its rules and regulations
then in effect or (ii) brought and enforced in the courts of the State of New York, County of New York, or the United States District
Court for the Southern District of New York, in each event at the discretion of the party initiating the dispute. Once a party
files a dispute with one of the above forums, the parties agree that all issues regarding such dispute or this Purchase Option
must be resolved before such forum rather than seeking to resolve it through another alternative forum set forth above. In the
event the dispute is brought before the Association, each of the parties agrees that the decision and/or award made by the arbitrators
shall be final and enforceable by any court having jurisdiction over the party from whom enforcement is sought. In the event the
dispute is brought by a party in the courts of the State of New York or the United States District Court for the Southern District
of New York, each party irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. Each party hereby waives
any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process or summons
to be served upon a party may be served by transmitting a copy thereof by registered or certified mail, return receipt requested,
postage prepaid, addressed to such party as indicated in Section 8.4 above. Such mailing shall be deemed personal service and shall
be legal and binding upon the party being served in any action, proceeding or claim. The parties agree that the prevailing party(ies)
in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and expenses
relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company hereby appoints,
without power of revocation, Broad and Cassel, 2 South Biscayne Boulevard, 21st Floor, Miami,
Florida 33131, Fax No.: (305) 373-9443, Attn: A. Jeffry Robinson, Esq., as its agent to accept and acknowledge on its behalf
service of any and all process which may be served in any arbitration, action, proceeding or counterclaim in any way relating to
or arising out of this Purchase Option.

 

9.6         Waiver, Etc.
The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Option shall not be deemed
or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Option or any provision
hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Option. No waiver
of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Option shall be effective unless set
forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and
no waiver of any such breach, non-compliance or non- fulfillment shall be construed or deemed to be a waiver of any other or subsequent
breach or non-compliance.

 

    	15

    	 

    

 

9.7         Execution
in Counterparts. This Purchase Option may be executed in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same
agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto.

 

9.8         Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Option, Holder agrees that, at any
time prior to the complete exercise of this Purchase Option by Holder, if the Company and EBC enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Options will be exchanged for securities or
cash or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

9.9         Intentionally Omitted.

 

    	16

    	 

    

 

IN WITNESS WHEREOF, the Company has caused
this Purchase Option to be signed by its duly authorized officer as of the ____ day of ___________, 2013.

 

	 	MEDWORTH acquisition
    CORP.
	 	 	 
	 	By:	 
	 	 	Name:  
	 	 	Title:

 

    	17

    	 

    

 

Form to be used to exercise Purchase Option:

 

MedWorth Acquisition Corp.

999 Brickell Avenue

Suite 800

Miami, Florida 33131

Fax No.: (305) 395-5219

Attn: Chief Executive Officer

 

Date:_________________, 20___

 

The undersigned hereby elects irrevocably
to exercise all or a portion of the within Purchase Option and to purchase ____ shares of Common Stock of MedWorth Acquisition
Corp. and hereby makes payment of $____________ (at the rate of $_________ per share of Common Stock) in payment of the Exercise
Price pursuant thereto. Please issue the securities as to which this Purchase Option is exercised in accordance with the instructions
given below.

 

or

 

The undersigned hereby elects irrevocably
to convert its right to purchase _________ shares of Common Stock purchasable under the within Purchase Option by surrender of
the unexercised portion of the attached Purchase Option (with a “Market Value” of $_______). Please issue the securities
comprising the shares of Common Stock as to which this Purchase Option is exercised in accordance with the instructions given below.

 

 

	 	NOTICE:  The signature to this assignment must correspond with the name as written upon the face of the purchase option in every particular, without alteration or enlargement or any change whatever.

 

Signature(s) Guaranteed:

 

 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY
AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

 

    	18

    	 

    

 

INSTRUCTIONS FOR REGISTRATION OF SECURITIES

 

	Name	 
	 	 
	 	(Print in Block Letters)
	 	 
	Address  	 
	 	 

 

    	19

    	 

    

 

Form to be used to assign Purchase Option:

 

ASSIGNMENT

 

(To be executed by the registered Holder
to effect a transfer of the within Purchase Option):

 

FOR VALUE RECEIVED,______________________________________________
does hereby sell, assign and transfer unto___________________________________________ the right to purchase __________ shares of
Common Stock of MedWorth Acquisition Corp. (“Company”) evidenced by the within Purchase Option and does
hereby authorize the Company to transfer such right on the books of the Company.

 

	Dated: ___________________, 20__	 
	 	 
	 	 
	 	Signature
	 	 
	 	 
	 	NOTICE:  The signature to this assignment must correspond with the name as written upon the face of the purchase option in every particular, without alteration or enlargement or any change whatever.
	 	 
	Signature(s) Guaranteed:	 
	 	 

 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY
AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

 

    	20Exhibit 10.2

 

INVESTMENT MANAGEMENT TRUST AGREEMENT

 

This Agreement is made as of ___________,
2013 by and between MedWorth Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (“Trustee”).

 

WHEREAS, the Company’s registration
statement on Form S-1, No. 333-188706 (“Registration Statement”) for its initial public offering (“IPO”)
of shares of its common stock, par value $.0001 per share (“Common Stock”), has been declared effective as of the date
hereof (“Effective Date”) by the Securities and Exchange Commission (capitalized terms used herein and not otherwise
defined shall have the meanings set forth in the Registration Statement); and

 

WHEREAS, EarlyBirdCapital, Inc. (“EBC”)
is acting as the representative of the underwriters in the IPO; and

 

WHEREAS, simultaneously with the IPO, the
Company’s initial stockholders will be purchasing an aggregate of 586,250 shares of Common Stock (which amount shall be increased
proportionately to up to 658,250 shares of Common Stock if a portion or all of the over-allotment option in connection with the
Company’s IPO is exercised) (“Sponsors’ Shares”) from the Company for an aggregate purchase price of $4,690,000,
or up to $5,266,000 if the over-allotment option is exercised in full; and

 

WHEREAS, as described in the Registration
Statement, and in accordance with the Company’s Amended and Restated Certificate of Incorporation, a portion of the gross
proceeds of the IPO and all of the gross proceeds from the sale of the Sponsors’ Shares (a total of $50,160,000, or $57,684,000
if the underwriters over-allotment option is exercised in full) will be delivered to the Trustee to be deposited and held in a
trust account for the benefit of the Company and the holders of the Company’s Common Stock issued in the IPO as hereinafter
provided (the aggregate amount to be delivered to the Trustee will be referred to herein as the “Property”; the stockholders
for whose benefit the Trustee shall hold the Property will be referred to as the “Public Stockholders,” and the Public
Stockholders and the Company will be referred to together as the “Beneficiaries”); and

 

WHEREAS, pursuant to the terms of a Merger
& Acquisition Agreement entered into between the Company and EBC in connection with the IPO, EBC is entitled to a fee (the
“Investment Banking Fee”) of $1,680,000 for acting as the Company’s investment banker in connection with the
Company’s initial business combination as described in the Registration Statement (“Business Combination”), which
Investment Banking Fee is to be paid upon closing of such Business Combination from the Trust Account (defined below); and

 

WHEREAS, the Company and the Trustee desire
to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property;

 

    	1

    	 

    

 

IT IS AGREED:

 

1.          Agreements
and Covenants of Trustee. The Trustee hereby agrees and covenants to:

 

(a)          Hold
the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in a segregated trust account (“Trust
Account”) established by the Trustee at JP Morgan Chase Bank, NA and at a brokerage institution selected by the Trustee that
is reasonably satisfactory to the Company;

 

(b)          Manage,
supervise and administer the Trust Account subject to the terms and conditions set forth herein;

 

(c)          In
a timely manner, upon the instruction of the Company, invest and reinvest the Property (i) in United States government treasury
bills having a maturity of 180 days or less and/or (ii) in money market funds meeting the conditions of paragraphs (c)(2),
(c)(3), (c)(4) and (c) (5) of Rule 2a-7 promulgated under the Investment Company Act of 1940, as
amended, and that invest solely in U.S. treasuries, as determined by the Company;

 

(d)          Collect
and receive, when due, all principal and income arising from the Property;

 

(e)          Notify
the Company within two (2) business days of all communications received by it with respect to any Property requiring action by
the Company;

 

(f)          Supply
any necessary information or documents as may be requested by the Company in connection with the Company’s preparation of
its tax returns;

 

(g)          Participate
in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when instructed
by the Company to do so;

 

(h)          Render
to the Company monthly written statements of the activities of and amounts in the Trust Account reflecting all receipts and disbursements
of the Trust Account; and

 

(i)          Commence
liquidation of the Trust Account only after and promptly after receipt of, and only in accordance with, the terms of a letter (“Termination
Letter”), in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B hereto, signed on behalf
of the Company by its President or Chairman of the Board and Secretary or Assistant Secretary and affirmed by counsel for the Company,
and complete the liquidation of the Trust Account and distribute the Property in the Trust Account only as directed in the Termination
Letter (which, in the case of Exhibit A, requires joint instructions from the Company and EBC and will include instructions to
pay the Investment Banking Fee from the Property on closing of the Business Combination) and the other documents referred to therein;
provided, however, that in the event that a Termination Letter has not been received by the Trustee by the 18-month anniversary
of the Effective Date (“Last Date”), the Trust Account shall be liquidated in accordance with the procedures set forth
in the Termination Letter attached as Exhibit B hereto and distributed to the stockholders of record on the record date established
by the Company for such purpose. The Company shall set the record date to be within ten days of the Last Date, or as soon thereafter
as reasonably practicable and legally permissible. The provisions of this Section 1(i) may not be modified, amended or deleted
under any circumstances.

 

    	2

    	 

    

 

2.          Limited
Distributions of Income on Property.

 

(a)          Upon
written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto
as Exhibit C, the Trustee shall distribute to the Company the amount of interest and other income earned on the Property requested
by the Company to cover any income or other tax obligation owed by the Company.

 

(b)          Upon
written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto
as Exhibit D, the Trustee shall distribute to the Company the amount of interest and other income earned on the Property requested
by the Company to cover expenses related to investigating and selecting a target business and other working capital requirements,
including but not limited to costs and expenses associated with the exercise of the over-allotment option, if applicable, and the
cost of the liquidation and dissolution of the Company, if applicable; provided, however, that the Company will not be allowed
to withdraw interest and other income earned on the Property unless there is an amount of interest and other income available in
the Trust Account sufficient to pay the Company’s tax obligations currently due and owing.

 

(c)          The
limited distributions referred to in Sections 2(a) and 2(b) above shall be made only from income collected on the Property. Except
as provided in Section 2(a), and 2(b) above, no other distributions from the Trust Account shall be permitted except in accordance
with Section 1(i) hereof.

 

3.          Agreements
and Covenants of the Company. The Company hereby agrees and covenants to:

 

(a)          Give
all instructions to the Trustee hereunder in writing, signed by the Company’s Chief Executive Officer, President, Vice President
or Chief Financial Officer. In addition, except with respect to its duties under paragraphs 1(i), 2(a) and 2(b) above, the Trustee
shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction which it in
good faith believes to be given by any one of the persons authorized above to give written instructions, provided that the Company
shall promptly confirm such instructions in writing;

 

(b)          Subject
to the provisions of Section 6(g) of this Agreement, hold the Trustee harmless and indemnify the Trustee from and against, any
and all expenses, including reasonable counsel fees and disbursements, or loss suffered by the Trustee in connection with any claim,
potential claim, action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim
or demand which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or
any income earned from investment of the Property, except for expenses and losses resulting from the Trustee’s gross negligence
or willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action,
suit or proceeding, pursuant to which the Trustee intends to seek indemnification under this paragraph, it shall notify the Company
in writing of such claim (hereinafter referred to as the “Indemnified Claim”). The Trustee shall have the right to
conduct and manage the defense against such Indemnified Claim, provided, that the Trustee shall obtain the consent of the Company
with respect to the selection of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to settle
any Indemnified Claim without the prior written consent of the Company which consent shall not be unreasonably withheld. The Company
may participate in such action with its own counsel;

 

    	3

    	 

    

 

(c)          Pay
the Trustee an initial acceptance fee, an annual fee and a transaction processing fee for each disbursement made pursuant to Sections
2(a) and 2(b) as set forth on Schedule A hereto, which fees shall be subject to modification by the parties from time to time.
It is expressly understood that the Property shall not be used to pay such fees and further agreed that any fees owed to the Trustee
shall be deducted by the Trustee from the disbursements made to the Company pursuant to Sections 1(i) solely in connection with
the consummation of a Business Combination, or pursuant to Section 2(b). The Company shall pay the Trustee the initial acceptance
fee and first year’s fee at the consummation of the IPO and thereafter on the anniversary of the Effective Date. The Trustee
shall refund to the Company the annual fee (on a pro rata basis) with respect to any period after the liquidation of the Trust
Fund;

 

(d)          In
connection with any vote of the Company’s stockholders regarding an Business Combination, provide to the Trustee an affidavit
or certificate of a firm regularly engaged in the business of soliciting proxies and/or tabulating stockholder votes verifying
the vote of the Company’s stockholders regarding such Business Combination;

 

(e)          The
Company shall provide EBC with a copy of any Termination Letters and/or any other correspondence that it issues to the Trustee
with respect to any proposed withdrawal from the Trust Account promptly after such issuance; and

 

(f)          In
the event that the Company directs the Trustee to commence liquidation of the Trust Account pursuant to Section 1(i), the Company
agrees that it will not direct the Trustee to make any payments that are not specifically authorized by this Agreement.

 

4.          Limitations
of Liability. The Trustee shall have no responsibility or liability to:

 

(a)          Take
any action with respect to the Property, other than as directed in paragraphs 1 and 2 hereof and the Trustee shall have no liability
to any party except for liability arising out of its own gross negligence or willful misconduct;

 

(b)          Institute
any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding of
any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided
herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses incident thereto;

 

(c)          Change
the investment of any Property, other than in compliance with paragraph 1(c);

 

    	4

    	 

    

 

(d)          Refund
any depreciation in principal of any Property;

 

(e)          Assume
that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless provided
otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;

 

(f)          The
other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted,
in good faith and in the exercise of its own best judgment, except for its gross negligence or willful misconduct. The Trustee
may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel
(including counsel chosen by the Trustee), statement, instrument, report or other paper or document (not only as to its due execution
and the validity and effectiveness of its provisions, but also as to the truth and acceptability of any information therein contained)
which is believed by the Trustee, in good faith, to be genuine and to be signed or presented by the proper person or persons. The
Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement or
any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee signed by the proper party or parties
and, if the duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;

 

(g)          Verify
the correctness of the information set forth in the Registration Statement or to confirm or assure that any acquisition made by
the Company or any other action taken by it is as contemplated by the Registration Statement;

 

(h)          File
local, state and/or Federal tax returns or information returns with any taxing authority on behalf of the Trust Account and payee
statements with the Company documenting the taxes, if any, payable by the Company or the Trust Account, relating to the income
earned on the Property;

 

(i)          Pay
any taxes on behalf of the Trust Account (it being expressly understood that the Property shall not be used to pay any such taxes
and that such taxes, if any, shall be paid by the Company from funds not held in the Trust Account or released to it under Section
2(a) hereof);

 

(j)          Imply
obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this agreement
and that which is expressly set forth herein; and

 

(k)          Verify
calculations, qualify or otherwise approve Company requests for distributions pursuant to Section 1(i), 2(a) or 2(b) above.

 

5.          Termination.
This Agreement shall terminate as follows:

 

    	5

    	 

    

 

(a)          If
the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable
efforts to locate a successor trustee during which time the Trustee shall act in accordance with this Agreement. At such time that
the Company notifies the Trustee that a successor trustee has been appointed by the Company and has agreed to become subject to
the terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including
but not limited to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this Agreement
shall terminate; provided, however, that, in the event that the Company does not locate a successor trustee within ninety days
of receipt of the resignation notice from the Trustee, the Trustee may submit an application to have the Property deposited with
any court in the State of New York or with the United States District Court for the Southern District of New York and upon such
deposit, the Trustee shall be immune from any liability whatsoever; or

 

(b)          At
such time that the Trustee has completed the liquidation of the Trust Account in accordance with the provisions of paragraph 1(i)
hereof, and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate
except with respect to Paragraph 3(b).

 

6.          Miscellaneous.

 

(a)          The
Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds
transferred from the Trust Account. Upon receipt of written instructions, the Trustee will confirm such instructions with an Authorized
Individual at an Authorized Telephone Number listed on the attached Exhibit E. The Company and the Trustee will each restrict access
to confidential information relating to such security procedures to authorized persons. Each party must notify the other party
immediately if it has reason to believe unauthorized persons may have obtained access to such information, or of any change in
its authorized personnel. In executing funds transfers, the Trustee will rely upon all information supplied to it by the Company,
including account names, account numbers and all other identifying information relating to a beneficiary, beneficiary’s bank
or intermediary bank. The Trustee shall not be liable for any loss, liability or expense resulting from any error in the information
or transmission of the wire.

 

(b)          This
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving
effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. It
may be executed in several original or facsimile counterparts, each one of which shall constitute an original, and together shall
constitute but one instrument.

 

(c)          This
Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter hereof. Except
for Section 1(i) (which may not be amended under any circumstances) and Sections 3(e) and 3(f) and the Company’s obligation
to pay the Investment Banking Fee upon the closing of an Business Combination from the Trust Account (which may not be changed,
amended or modified without the prior written consent of EBC), this Agreement or any provision hereof may only be changed, amended
or modified by a writing signed by each of the parties hereto. As to any claim, cross-claim or counterclaim in any way relating
to this Agreement, each party waives the right to trial by jury. The Trustee may require from Company counsel an opinion as to
the propriety of any proposed amendment.

 

    	6

    	 

    

 

(d)          The
parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, Borough of
Manhattan, for purposes of resolving any disputes hereunder.

 

(e)          Any
notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing
and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery
or by facsimile transmission:

 

	if to the Trustee, to:
	 	 
	 	Continental Stock Transfer 
	 	  & Trust Company
	 	17 Battery Place  
	 	New York, New York 10004
	 	Attn:  Steven G. Nelson, Chairman, and Frank A. DiPaolo, CFO
	 	Fax No.:  (212) 509-5150
	 	 
	if to the Company, to:
	 	 
	 	MedWorth Acquisition Corp. 
	 	999 Brickell Avenue, Suite 800
	 	Miami, Florida 33131
	 	Attn:  Charles F. Fistel
	 	Fax No.:  (305) 395-5219
	 	 
	in either case with a copy to:
	 	 
	 	EarlyBirdCapital, Inc.
	 	275 Madison Avenue, 27th Floor
	 	New York, New York 10016
	 	Attn:  Steven Levine
	 	Fax No.:  (___) ___-____
	 	 
	 	And
	 	 
	 	Broad and Cassel
	 	2. S. Biscayne Boulevard, Suite 2100
	 	Miami, Florida 33131
	 	Attn: A. Jeffry Robinson
	 	Fax No: (305) 373-9443

 

(f)          This
Agreement may not be assigned by the Trustee without the prior consent of the Company.

 

    	7

    	 

    

 

(g)          Each
of the Trustee and the Company hereby represents that it has the full right and power and has been duly authorized to enter into
this Agreement and to perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it
shall not make any claims or proceed against the Trust Account, including by way of set-off, and shall not be entitled to any funds
in the Trust Account under any circumstance. In the event that the Trustee has a claim against the Company under this Agreement,
the Trustee will pursue such claim solely against the Company and not against the Property held in the Trust Account.

 

(h)          Each
of the Company and the Trustee hereby acknowledge that EBC is a third party beneficiary of this Agreement.

 

[Signature Page Follows]

 

    	8

    	 

    

 

IN WITNESS WHEREOF, the parties have duly executed this Investment
Management Trust Agreement as of the date first written above.

  

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Trustee
	 	 
	 	By:	 
	 	 	Name:  Frank A. Di Paolo
	 	 	Title:  Trust Officer
	 	 	 
	 	MEDWORTH ACQUISITION CORP. 
	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title:
	 	 	 	 

 

    	9

    	 

    

 

SCHEDULE A

 

	Fee Item	 	Time and method of payment	 	Amount	 
	Initial acceptance fee	 	Initial closing of IPO by wire transfer	 	$	3,500	 
	Annual fee	 	First year, initial closing of IPO by wire transfer; thereafter on the anniversary of the effective date of the IPO by wire transfer or check	 	$	10,000	 
	Transaction processing fee for disbursements to Company under Section 2	 	Deduction by Trustee from accumulated income following disbursement made to Company under Section 2	 	$	250	 
	Paying Agent services as required pursuant to section 1(i)	 	Billed to Company upon delivery of service pursuant to section 1(i)	 	 	
Prevailing rates
  
	

 

    	10

    	 

    

 

EXHIBIT A

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer

& Trust Company

17 Battery Place

New York, New York 10004

Attn: Steven Nelson and Frank DiPaolo

 

Re:           Trust Account No. - Termination Letter

 

Gentlemen:

 

Pursuant to paragraph
1(i) of the Investment Management Trust Agreement between MedWorth Acquisition Corp. (“Company”) and Continental Stock
Transfer & Trust Company (“Trustee”), dated as of _________, 2013 (“Trust Agreement”), this is to advise
you that the Company has entered into an agreement (“Business Agreement”) with __________________ (“Target Business”)
to consummate a business combination with Target Business (“Business Combination”) on or about [insert date].
The Company shall notify you at least 48 hours in advance of the actual date of the consummation of the Business Combination (“Consummation
Date”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Trust Agreement.

 

In accordance with the
terms of the Trust Agreement, we hereby authorize you to liquidate the Trust Account investments on __________ and to transfer
the proceeds to the above-referenced account at UBS Financial Services Inc. to the effect that, on the Consummation Date, all of
the funds held in the Trust Account will be immediately available for transfer to the account or accounts that the Company shall
direct on the Consummation Date. It is acknowledged and agreed that while the funds are on deposit in the Trust Account awaiting
distribution, the Company will not earn any interest or dividends.

 

On the Consummation Date
(i) counsel for the Company shall deliver to you written notification that the Business Combination has been consummated, or will,
concurrently with your transfer of funds to the accounts as directed by the Company be consummated, and (ii) the Company shall
deliver to you (a) [an affidavit] [a certificate] of the Chief Executive Officer, which verifies that the Business Combination
has been approved by the vote of the Company’s stockholders, if a vote is held and (b) joint written instructions from it
and EarlyBirdCapital, Inc. with respect to the transfer of the funds held in the Trust Account, including payment of the Investment
Banking Fee from the Trust Account (“Instruction Letter”). You are hereby directed and authorized to transfer the funds
held in the Trust Account immediately upon your receipt of the counsel's letter and the Instruction Letter, in accordance with
the terms of the Instruction Letter. In the event that certain deposits held in the Trust Account may not be liquidated by the
Consummation Date without penalty, you will notify the Company of the same and the Company shall direct you as to whether such
funds should remain in the Trust Account and be distributed after the Consummation Date to the Company or be distributed immediately
and the penalty incurred. Upon the distribution of all the funds in the Trust Account pursuant to the terms hereof, the Trust Agreement
shall be terminated.

 

    	11

    	 

    

 

In the event that the
Business Combination is not consummated on the Consummation Date described in the notice thereof and we have not notified you on
or before the original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from
the Company, the funds held in the Trust Account shall be reinvested as provided in the Trust Agreement on the business day immediately
following the Consummation Date as set forth in the notice.

 

	 	Very truly yours,
	 	 
	 	MEDWORTH ACQUISITION CORP.
	 	 
	 	By:	 	 
	 	 
	 	By:	 	 

 

cc: EarlyBirdCapital, Inc.

 

    	12

    	 

    

 

EXHIBIT B

 

[Letterhead of Company]

 

[Insert date]

Continental Stock Transfer

& Trust Company

17 Battery Place

New York, New York 10004

Attn: Steven Nelson and Frank DiPaolo

 

Re:           Trust Account No. - Termination Letter

 

Gentlemen:

 

Pursuant to paragraph 1(i) of the Investment
Management Trust Agreement between MedWorth Acquisition Corp. (“Company”) and Continental Stock Transfer & Trust
Company (“Trustee”), dated as of ________, 2013 (“Trust Agreement”), this is to advise you that the Company
has been unable to effect a Business Combination within the time frame specified in the Company’s Amended and Restated Certificate
of Incorporation, as described in the Company’s prospectus relating to its IPO. Capitalized terms used herein and not otherwise
defined shall have the meanings set forth in the Trust Agreement.

 

In accordance with the terms of the Trust
Agreement, we hereby authorize you to liquidate all the Trust Account investments on or before ______________ and to transfer the
total proceeds to the Trust Checking Account at UBS Financial Services Inc. to await distribution to the Company’s Public
Stockholders. The Company has selected ____________, 20__ as the record date for the purpose of determining the Public Stockholders
entitled to receive their share of the liquidation proceeds. It is acknowledged that no interest will be earned by the Company
on the liquidation proceeds while on deposit in the Trust Checking Account. You agree to be the Paying Agent of record and in your
separate capacity as Paying Agent, to distribute said funds directly to the Company’s Public Stockholders in accordance with
the terms of the Trust Agreement and the Amended and Restated Certificate of Incorporation of the Company. Upon the distribution
of all the funds in the Trust Account, your obligations under the Trust Agreement shall be terminated.

 

	 	Very truly yours,
	 	 
	 	MEDWORTH ACQUISITION CORP.
	 	 
	 	By:	 	 
	 	 
	 	By:	 	 

 

 

cc: EarlyBirdCapital, Inc.

    	13

    	 

    

 

EXHIBIT C

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer

& Trust Company

17 Battery Place

New York, New York 10004

Attn: Frank Di Paolo and Cynthia Jordan

 

Re:           Trust Account No. 

 

Gentlemen:

 

Pursuant to paragraph 2(a) of the Investment
Management Trust Agreement between MedWorth Acquisition Corp. (“Company”) and Continental Stock Transfer & Trust
Company (“Trustee”), dated as of ___________, 2013 (“Trust Agreement”), the Company hereby requests that
you deliver to the Company $_______ of the interest and other income earned on the Property as of the date hereof. The Company
needs such funds to pay its tax obligations. In accordance with the terms of the Trust Agreement, you are hereby directed and authorized
to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s operating account at:

 

[WIRE INSTRUCTION INFORMATION]

 

	 	MEDWORTH ACQUISITION CORP.
	 	 
	 	By:	 	 
	 	 
	 	By:	 	 

 

cc: EarlyBirdCapital, Inc.

    	14

    	 

    

 

EXHIBIT D

 

[Letterhead of Company]

 

[Insert date]

 

Continental Stock Transfer

& Trust Company

17 Battery Place

New York, New York 10004

Attn: Frank Di Paolo and Cynthia Jordan

 

Re:           Trust Account No. 

 

Gentlemen:

 

Pursuant to paragraph 2(b) of the Investment
Management Trust Agreement between MedWorth Acquisition Corp. (“Company”) and Continental Stock Transfer & Trust
Company (“Trustee”), dated as of __________, 2013 (“Trust Agreement”), the Company hereby requests that
you deliver to the Company $_______ of the interest and other income earned on the Property as of the date hereof. The Company
needs such funds to cover its expenses relating to investigating and selecting a target business and other working capital requirements,
including but not limited to expenses relating to the exercise of the over-allotment option, if applicable, and expenses related
to the liquidation and dissolution of the Company, if applicable. In accordance with the terms of the Trust Agreement, you are
hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s
operating account at:

 

[WIRE INSTRUCTION INFORMATION]

 

	 	Very truly yours,
	 	 
	 	MEDWORTH ACQUISITION CORP.
	 	 
	 	By:	 	 
	 	 
	 	By:	 	 

 

cc: EarlyBirdCapital, Inc.

    	15

    	 

    

 

EXHIBIT E

 

Authorized Individuals and Authorized
Telephone Numbers

 

 

    	16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]